Search
for
Sort by
Research 91–120 of 1000+
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- Prostate-specific antigen as a diagnostic marker in female hyperandrogenism
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Treatment of hyperandrogenism in women
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome.
- Evidence-based approach to cutaneous hyperandrogenism in women
- Implications of Non-compliance in the Management of Chronic Polycystic Ovarian Syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Insulin Resistance and Polycystic Ovary Syndrome
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Clinico-investigative profile of patients of hirsutism in a tertiary level institution
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Current aspects of polycystic ovary syndrome: A literature review
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- To evaluate the outcome of combined therapy of cyproterone acetate and ethinyl estradiol in PCOS
- Oligomenorrhoea in Exercising Women
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Androgen excess and post-reproductive health